menu
    • menu

    Company profile for Melinta Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to meet the continually evolving threat of bacterial infections by discovering, developing, and commercializing a continual stream of novel antibiotics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Melinta TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6663, 300 George St #301, New Haven, CT 06511, United States
    Telephone
    Telephone
    +1 844‑633‑6568
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://melinta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/melinta-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MelintaTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CorMedix buys Melinta for $300M, Adding 7 Marketed Products
    CorMedix buys Melinta for $300M, Adding 7 Marketed Products

    08 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/cormedix-expands-its-portfolio-300m-acquisition-melinta

    FIERCE PHARMA
    08 Aug 2025
    Share Share
    CorMedix to Acquire Melinta, Expand Acute Care Portfolio
    CorMedix to Acquire Melinta, Expand Acute Care Portfolio

    07 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/07/3129080/0/en/CorMedix-to-acquire-Melinta-Therapeutics-Creating-Diversified-Specialty-Company-With-Strong-Presence-in-Acute-Care-Settings.html

    GLOBENEWSWIRE
    07 Aug 2025
    Share Share
    Melinta Joins NHIA Future of Infusion Advisory Council
    Melinta Joins NHIA Future of Infusion Advisory Council

    02 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241202121140/en

    BUSINESSWIRE
    02 Dec 2024
    Share Share
    Melinta Announces IDWeek 2024 Presentations On Product Portfolio
    Melinta Announces IDWeek 2024 Presentations On Product Portfolio

    16 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016869619/en

    BUSINESSWIRE
    16 Oct 2024
    Share Share
    Melinta Therapeutics Appoints Chief Technology Officer
    Melinta Therapeutics Appoints Chief Technology Officer

    05 Sep 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-09-05/melinta-therapeutics-appoints-chief-technology-officer/?widget=listSection

    CONTRACT PHARMA
    05 Sep 2024
    Share Share
    Melinta Therapeutics Appoints Sunitha as Chief Technology Officer
    Melinta Therapeutics Appoints Sunitha as Chief Technology Officer

    05 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240905516181/en

    BUSINESSWIRE
    05 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search